We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

92 hedge funds and large institutions have $792M invested in Praxis Precision Medicines in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

124% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 17

15% more funds holding

Funds holding: 80 → 92 (+12)

5% more capital invested

Capital invested by funds: $751M → $792M (+$40.8M)

0.09% more ownership

Funds ownership: 6.29% → 6.38% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
92
Holders Change
+12
Holders Change %
+15%
% of All Funds
1.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
38
Reduced
17
Closed
9
Calls
$406K
Puts
–
Net Calls
+$406K
Net Calls Change
+$531K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$11.9M
2
BlackRock
BlackRock
New York
+$11.4M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.33M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$5.44M
5
GTC
Ghost Tree Capital
New York
+$4.52M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$11.9M
2
Blackstone Inc
Blackstone Inc
New York
-$8.33M
3
Citadel Advisors
Citadel Advisors
Florida
-$3.98M
4
MIM
Monashee Investment Management
Massachusetts
-$1.83M
5
Morgan Stanley
Morgan Stanley
New York
-$1.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Blackstone Inc
1
Blackstone Inc
New York
$98.7M -$8.33M -30,722 -8%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$86.1M -$834K -3,074 -1%
EAM
3
Eventide Asset Management
Massachusetts
$70.5M +$426K +1,570 +0.6%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$60.6M +$5.44M +20,045 +10%
Vanguard Group
5
Vanguard Group
Pennsylvania
$59.3M +$11.9M +44,012 +26%
VVA
6
Vida Ventures Advisors
Massachusetts
$54.3M – – –
BlackRock
7
BlackRock
New York
$39.7M +$11.4M +42,046 +42%
AllianceBernstein
8
AllianceBernstein
Tennessee
$30.4M +$4.08M +15,042 +16%
Citadel Advisors
9
Citadel Advisors
Florida
$30.3M -$3.98M -14,679 -12%
ACA
10
Avoro Capital Advisors
New York
$29.6M – – –
AG
11
Artal Group
Luxembourg
$22.2M – – –
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$21M +$6.33M +23,334 +44%
CAM
13
Cormorant Asset Management
Massachusetts
$18.9M +$271 +1 +0%
7IH
14
72 Investment Holdings
Connecticut
$18.3M – – –
HMC
15
Harvard Management Company
Massachusetts
$14.4M – – –
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$11.3M +$452K +1,666 +4%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$10.8M +$4.34M +16,016 +70%
State Street
18
State Street
Massachusetts
$9.39M +$2.83M +10,439 +45%
LCM
19
Laurion Capital Management
New York
$9.14M +$16.5K +61 +0.2%
PHS
20
PFM Health Sciences
California
$8.42M – – –
KCM
21
Kingdon Capital Management
New York
$7.66M +$2.97M +10,966 +66%
Verition Fund Management
22
Verition Fund Management
Connecticut
$7.62M -$2.98K -11 -0%
WP
23
Woodline Partners
California
$5.71M -$863K -3,180 -13%
Northern Trust
24
Northern Trust
Illinois
$5.51M +$1.36M +5,003 +34%
Franklin Resources
25
Franklin Resources
California
$5.08M – – –
1
2 3 4 5

PRAX Hedge Fund Activity: Q3 2021 in Review

92 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q3 2021, worth a combined $792M — up 5.4% from $751M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new PRAX positions and 9 closed out — a net gain of 12 holders — while 38 added to existing stakes and 17 trimmed.

The largest buyer was Vanguard Group, adding an estimated $11.9M. The largest seller was Novo Holdings A/S, cutting an estimated $11.9M.

  • 92 institutional investors held Praxis Precision Medicines (PRAX) as of Q3 2021, up from 80 in Q2 2021.
  • Funds reported $792M of Praxis Precision Medicines stock for Q3 2021, up 5.4% quarter-over-quarter.
  • 21 funds opened new Praxis Precision Medicines positions in Q3 2021 and 9 closed out, a net change of +12 holders.
  • The largest Praxis Precision Medicines buyer in Q3 2021 was Vanguard Group, an estimated $11.9M added.
  • The largest Praxis Precision Medicines seller in Q3 2021 was Novo Holdings A/S, an estimated $11.9M sold.

Based on aggregated 13F filings for Q3 2021.